IBD Plexus Publications
05/09/2023
SPARC IBD
Sex-based Differences in Drug Durability Among Patients with Inflammatory Bowel Diseases
Digestive Diseases Week (DDW)
Abstract/Poster05/09/2023
SPARC IBD
Sex-based Differences in Clinical and Endoscopic Outcomes Among Patients with Inflammatory Bowel Diseases
Digestive Diseases Week (DDW)
Abstract/Poster05/09/2023
SPARC IBD
Blood-based DNA Methylation Biomarkers to Distinguish Irritable Bowel Syndrome, Inflammatory Bowel Disease and Celiac Disease
Digestive Diseases Week (DDW)
Abstract/Poster05/06/2023
SPARC IBD
Healthcare resource utilization 18-Month Follow-up of Crohn’s Disease Patients Stratified by Severity
Digestive Diseases Week (DDW)
Abstract/Poster05/02/2023
Pediatric Risk
The Clinical Response of Upadacitinib and Risankizumab Is Associated With Reduced Inflammatory Bowel Disease Anti-TNF-α Inadequate Response Mechanisms
Inflammatory Bowel Diseases
Publication03/30/2023
IBD Partners
Results from the COMPARE Study – How Do Different Medications Impact IBD Patients? Crohn's Disease
Digestive Diseases and Sciences
Manuscript03/20/2023
SPARC IBD
Interpretable histopathology-based prediction of disease relevant features in Inflammatory Bowel Disease biopsies using weakly-supervised deep learning
arXiv
Publication02/23/2023
SPARC IBD
Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease
Nature Medicine
Manuscript02/12/2023
SPARC IBD
Second-Line Biologic Therapy Following Tumor Necrosis Factor Antagonist Failure: A Real-World Propensity Score-Weighted Analysis
Clinical Gastroenterology and Hepatology
Publication02/11/2023
SPARC IBD
Second-Line Biologic Therapy Following Tumor Necrosis Factor Antagonist Failure: A Real-World Propensity Score-Weighted Analysis
Clinical Gastroenterology and Hepatology
Manuscript